Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 566Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Systematic Review of Early Phase Pediatric Clinical Pharmacology Trials
Deejesh Subramanian,Cintia V. Cruz,Facundo Garcia-Bournissen
The Journal of Pediatric Pharmacology and Therapeutics.2022;27(7)609
[DOI]
2Clinical Pharmacology Studies in Critically Ill Children
Nilay Thakkar,Sara Salerno,Christoph P. Hornik,Daniel Gonzalez
Pharmaceutical Research.2017;34(1)7
[DOI]
3Pediatric data from the All of Us research program: demonstration of pediatric obesity over time
Nicholas P Giangreco,Sulieman Lina,Jun Qian,Aymone Kouame,Vignesh Subbian,Eric Boerwinkle,Mine Cicek,Cheryl R Clark,Elizabeth Cohen,Kelly A Gebo,Roxana Loperena-Cortes,Kelsey Mayo,Stephen Mockrin,Lucila Ohno-Machado,Sheri D Schully,Nicholas P Tatonetti,Andrea H Ramirez
JAMIA Open.2021;4(4)7
[DOI]
4Cultural, geographical and ethical questions when looking to enroll pediatric patients in rare disease clinical trials
Stefan Anzelewicz,Hanna Garnier,Arun Rangaswami,Piotr Czauderna
Expert Opinion on Orphan Drugs.2017;5(8)613
[DOI]
5A group-sequential randomized trial design utilizing supplemental trial data
Ales Kotalik,David M. Vock,Brian P. Hobbs,Joseph S. Koopmeiners
Statistics in Medicine.2022;41(4)698
[DOI]
6A group-sequential randomized trial design utilizing supplemental trial data
Edel Mc Glanaghy,Nina Di Pietro,Benjamin Wilfond
Statistics in Medicine.2015;41(4)91
[DOI]
7A group-sequential randomized trial design utilizing supplemental trial data
Brian Smith,Alyse Ley,Katherine Krive,Jed Magen
Statistics in Medicine.2019;41(4)69
[DOI]
8Conducting community-based pediatric research in rural India: Experience from vadu rural health program
Aditi Apte,Girish Dayma,Himangi Lubree,Anand Kawade,Sanjay Juvekar,Ashish Bavdekar
Perspectives in Clinical Research.2021;12(3)126
[DOI]
9In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant
Simon D. van Haren,Lakshmi Ganapathi,Ilana Bergelson,David J. Dowling,Michaela Banks,Ronald C. Samuels,Steven G. Reed,Jason D. Marshall,Ofer Levy
Cytokine.2016;83(3)99
[DOI]
10Nanomedicines for Pediatric Cancers
Carlos Rodríguez-Nogales,Yolanda González-Fernández,Azucena Aldaz,Patrick Couvreur,María J. Blanco-Prieto
ACS Nano.2018;12(8)7482
[DOI]
11Nanomedicines for Pediatric Cancers
Simon Woods
ACS Nano.2018;12(8)1
[DOI]
12How to select the initial dose for a pediatric study?
Jingjing Ye,Youwei Bi,Naitee Ting
Journal of Biopharmaceutical Statistics.2022;12(8)1
[DOI]
13Clinical trials: Kids are not just little people
Fludiona Naka,Bruce Strober,Mona Shahriari
Clinics in Dermatology.2017;35(6)583
[DOI]
14Handling Poor Accrual in Pediatric Trials: A Simulation Study Using a Bayesian Approach
Danila Azzolina,Giulia Lorenzoni,Silvia Bressan,Liviana Da Dalt,Ileana Baldi,Dario Gregori
International Journal of Environmental Research and Public Health.2021;18(4)2095
[DOI]
15How to Conduct Clinical Trials in Children: A Tutorial
Valentina Shakhnovich,Christoph P. Hornik,Gregory L. Kearns,Jaylene Weigel,Susan M. Abdel-Rahman
Clinical and Translational Science.2019;12(3)218
[DOI]
16Clinical trials in children
Pathma D. Joseph,Jonathan C. Craig,Patrina H.Y. Caldwell
British Journal of Clinical Pharmacology.2015;79(3)357
[DOI]
17Implementation of a Plan–Do–Study–Act framework to reduce unindicated surgical antimicrobial prophylaxis
Mark Kashtan,Michele Dawson,Seema Anandalwar,Jonathan Hills-Dunlap,Dionne A. Graham,Shawn Rangel
Journal of Pediatric Surgery.2020;55(1)86
[DOI]
18Non-static framework for understanding adaptive designs: an ethical justification in paediatric trials
Michael OS Afolabi,Lauren E Kelly
Journal of Medical Ethics.2021;55(1)medethics-2021-107263
[DOI]
19Optimizing interim analysis timing for Bayesian adaptive commensurate designs
Xiao Wu,Yi Xu,Bradley P. Carlin
Statistics in Medicine.2020;39(4)424
[DOI]
20A Bayesian approach in design and analysis of pediatric cancer clinical trials
Jingjing Ye,Gregory Reaman,R. Angelo De Claro,Rajeshwari Sridhara
Pharmaceutical Statistics.2020;19(6)814
[DOI]
21Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies
Mary Rensel
Children.2019;6(6)73
[DOI]
22Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Jean C. Dinh,Chelsea M. Hosey-Cojocari,Bridgette L. Jones
Pediatric Drugs.2020;22(1)55
[DOI]
23Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities
Mariana Salles La Terza Velleca
Pediatric Drugs.2014;22(1)196
[DOI]
24Enhancing the Pediatric Drug Development Framework to Deliver Better Pediatric Therapies Tomorrow
Christina Bucci-Rechtweg
Clinical Therapeutics.2017;39(10)1920
[DOI]
25The Current Status of European and National Financial Sources for Clinical Research and Their Impact on Paediatric Non-commercial Clinical Trials: A Case Study of the Czech Republic
L. Horavova,K. Nebeska,L. Souckova,R. Demlova,P. Babula
Therapeutic Innovation & Regulatory Science.2020;54(6)1461
[DOI]
26Experimental Therapeutic Trial Design for Pediatric Brain Tumors
Miriam Bornhorst,Eugene I. Hwang
Journal of Child Neurology.2016;31(12)1421
[DOI]
27Landscape of Pediatric Biobanking: Challenges and Current Efforts
Lalita Wadhwa
Biopreservation and Biobanking.2021;19(2)119
[DOI]
28Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
Leslie A Mandel,Ellen O’Donnell,Katia Canenguez,Paola B Castro-Mendoza,Tim Lotze,Emmanuelle Waubant,Bianca Weinstock-Guttmann,Tanuja Chitnis
Journal of Patient Experience.2021;8(2)237437352110393
[DOI]
29Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
Christine R. Totri,Lawrence F. Eichenfield
Journal of Patient Experience.2015;8(2)161
[DOI]
30Paediatric clinical research in Europe: an insight on experts’ needs and perspectives
Lucia Ruggieri,Adriana Ceci,Franco Bartoloni,Valèry Elie,Mariagrazia Felisi,Evelyne Jacqz-Aigrain,Mariangela Lupo,Salma Malik,Cristina Manfredi,Giorgio Reggiardo,Jacques Demotes,Donato Bonifazi
Contemporary Clinical Trials Communications.2021;21(2)100735
[DOI]
31Parents’ attitudes towards and perceptions of involving minors in medical research from the Japanese perspective
Yasue Fukuda,Koji Fukuda
BMC Medical Ethics.2018;19(1)100735
[DOI]
32From tokenism to meaningful engagement: best practices in patient involvement in an EU project
David Supple,Amanda Roberts,Val Hudson,Sarah Masefield,Neil Fitch,Malayka Rahmen,Breda Flood,Willem de Boer,Pippa Powell,Scott Wagers
Research Involvement and Engagement.2015;1(1)100735
[DOI]
33The culture of research communication in neonatal intensive care units: key stakeholder perspectives
Jennifer Degl,Ronald Ariagno,Judy Aschner,Sandra Beauman,Wakako Eklund,Elissa Faro,Hiroko Iwami,Yamile Jackson,Carole Kenner,Ivone Kim,Agnes Klein,Mary Short,Keira Sorrells,Mark A. Turner,Robert Ward,Scott Winiecki,Christina Bucci-Rechtweg
Journal of Perinatology.2021;41(12)2826
[DOI]
34Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
Marisa McGinley,Ian T. Rossman
Neurotherapeutics.2017;14(4)985
[DOI]
35Health Disparities in Environmental and Occupational Lung Disease
Emily Brigham,Kassandra Allbright,Drew Harris
Clinics in Chest Medicine.2020;41(4)623
[DOI]
36Effective and safe pharmacotherapy for pediatric population: a call for academia to conduct clinical research
Melva Louisa
Medical Journal of Indonesia.2018;27(4)221
[DOI]
37Medicines for Pediatric Patients—Biopharmaceutical, Developmental, and Regulatory Considerations
David P. Elder,René Holm,Martin Kuentz
Journal of Pharmaceutical Sciences.2017;106(4)950
[DOI]
38Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
Mary A. Ott,Francis P. Crawley,Xavier Sáez-Llorens,Seth Owusu-Agyei,David Neubauer,Gary Dubin,Tatjana Poplazarova,Norman Begg,Susan L. Rosenthal
Pediatric Drugs.2018;20(3)215
[DOI]
39Pediatric Clinical Trials Conducted in South Korea from 2006 to 2015: An Analysis of the South Korean Clinical Research Information Service, US ClinicalTrials.gov and European Clinical Trials Registries
Sheung-Nyoung Choi,Ji-Hyun Lee,In-Kyung Song,Eun-Hee Kim,Jin-Tae Kim,Hee-Soo Kim
Pediatric Drugs.2017;19(6)569
[DOI]
40Pediatric Trials Run in India: An Analysis of Clinical Trials.gov 2006–2015
Giulia Lorenzoni,Rosanna Irene Comoretto,Mariangela Ruffolo,Danila Azzolina,Ileana Baldi
The Indian Journal of Pediatrics.2019;86(S1)10
[DOI]
41Ethics of Conducting Clinical Research in an Outbreak Setting
Kathryn M. Edwards,Sonali Kochhar
Annual Review of Virology.2020;7(1)475
[DOI]
42Improving Early Futility Determination by Learning from External Data in Pediatric Cancer Clinical Trials
Jingjing Ye,Gregory Reaman
Statistics in Biosciences.2022;14(2)337
[DOI]
43Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
Miriam Bornhorst,Eugene I. Hwang
Pediatric Drugs.2020;22(1)45
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal